InnoCan Pharma Corporation (INNPF)
USD 0.14
(16.67%)
USD 0.14
(16.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.65 Million | 2.55 Million | 196 Thousand | 8000.00 | - | - |
| Cost of Revenue | 1.67 Million | 452 Thousand | 75 Thousand | 5000.00 | 23.53 Thousand | - |
| Gross Profit | 11.97 Million | 2.1 Million | 121 Thousand | 3000.00 | -23.53 Thousand | - |
| Operating Expenses | 8.17 Million | 8.37 Million | 7.6 Million | 4.72 Million | 3 Million | 1.16 Million |
| Selling, General and Administrative Expenses | 13.98 Million | 6.84 Million | 6.2 Million | 3.23 Million | 2.63 Million | 632 Thousand |
| Research and Development Expenses | 1.79 Million | 1.52 Million | 1.39 Million | 1.36 Million | 368 Thousand | 534 Thousand |
| Other Expenses | -7.6 Million | - | - | - | - | - |
| Cost and Expenses | 9.85 Million | 8.82 Million | 7.67 Million | 4.73 Million | 3 Million | 1.16 Million |
| Operating Income | 3.8 Million | -6.26 Million | -7.48 Million | -4.72 Million | -3 Million | -1.16 Million |
| Interest Expense | - | 2000.00 | 13 Thousand | 5.22 Million | 334 Thousand | 26 Thousand |
| Income Tax Expense | 214 Thousand | 1000.00 | -31 Thousand | -166.29 Thousand | -148.86 Thousand | -161.14 Thousand |
| Earnings before Tax | -4.03 Million | -3.88 Million | -10.09 Million | -9.95 Million | -3.33 Million | -1.19 Million |
| Net Income | -4.7 Million | -3.76 Million | -10.04 Million | -9.95 Million | -3.33 Million | -1.19 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.04 | -0.06 | -0.02 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.04 | -0.06 | -0.02 | -0.01 |
| Weighted Average Shares Outstanding | 257.01 Million | 248.95 Million | 224.54 Million | 162.02 Million | 143.86 Million | 143.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 257 Million | 248.95 Million | 224.54 Million | 162.02 Million | 143.86 Million | 143.86 Million |
| Gross Margin | 0.88 | 0.82 | 0.62 | 0.38 | - | - |
| EBIT Margin | -0.28 | -2.43 | -37.94 | -585.62 | - | - |
| Profit Margin | -0.34 | -1.47 | -51.26 | -1244.12 | - | - |
| EBITDA | -3.77 Million | -3.69 Million | -7.43 Million | -4.68 Million | -2.97 Million | - |
| Earnings Before Tax Margin | 0.28 | -2.45 | -38.16 | -590.62 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.64 Million | 6.73 Million | 13.9 Million | 5.02 Million | 4.08 Million | 3.12 Million |
| Cost of Revenue | 645.86 Thousand | 763.57 Thousand | 1.7 Million | 620.69 Thousand | 419 Thousand | 465 Thousand |
| Gross Profit | 7.99 Million | 5.97 Million | 12.19 Million | 4.4 Million | 3.66 Million | 2.65 Million |
| Operating Expenses | 7.46 Million | 7.18 Million | 16.07 Million | 5.32 Million | 4.87 Million | 3.09 Million |
| Selling, General and Administrative Expenses | 7.03 Million | 6.75 Million | - | 4.8 Million | 4.43 Million | 2.83 Million |
| Research and Development Expenses | 424.91 Thousand | 422.1 Thousand | - | 517.92 Thousand | 431 Thousand | 257 Thousand |
| Other Expenses | 1.00 | - | - | - | - | - |
| Cost and Expenses | 8.11 Million | 7.94 Million | 17.78 Million | 5.94 Million | 5.28 Million | 3.55 Million |
| Operating Income | 531.89 Thousand | -1.2 Million | -3.87 Million | -918.7 Thousand | -1.2 Million | 436 Thousand |
| Interest Expense | - | 5000.00 | - | - | 3000.00 | 1000.00 |
| Income Tax Expense | 477.9 Thousand | 232.95 Thousand | 217.92 Thousand | 219.91 Thousand | 203 Thousand | 125 Thousand |
| Earnings before Tax | 1.43 Million | -1.21 Million | -4.1 Million | -598.08 Thousand | -1.82 Million | -396 Thousand |
| Net Income | 337 Thousand | -1.75 Million | -4.78 Million | -907.4 Thousand | -2.02 Million | -520 Thousand |
| Earnings Per Share Basic | 0.00 | -0.01 | - | -0.00 | -0.01 | -0.00 |
| Earnings Per Share Diluted | 0.00 | -0.01 | - | -0.00 | -0.01 | -0.00 |
| Weighted Average Shares Outstanding | 280.66 Million | 269.81 Million | 257 Million | 268 Million | 258.28 Million | 251.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 280.66 Million | 269.81 Million | 257 Million | 268 Million | 258.28 Million | 251.87 Million |
| Gross Margin | 0.93 | 0.89 | 0.88 | 0.88 | 0.90 | 0.85 |
| EBIT Margin | 0.06 | -0.18 | - | -0.18 | -0.29 | -0.14 |
| Profit Margin | 0.04 | -0.26 | -0.34 | -0.18 | -0.50 | -0.17 |
| EBITDA | 541.88 Thousand | -1.19 Million | - | -910.48 Thousand | -1.19 Million | -424 Thousand |
| Earnings Before Tax Margin | 0.06 | -0.18 | -0.28 | -0.18 | -0.30 | 0.14 |
BABB
STN
ASP
GALT
CTRYY
EDD